COMP <GO>
STIM vs UTMD // GROSS PROFIT MARGIN
Neuronetics Inc. (NASDAQ) VS. Utah Medical Products Inc. (NASDAQ) • 15-METRIC TALLY: STIM 3
— UTMD 6
▲ GROSS PROFIT MARGIN LEADER: UTMD
LAST: $2.25 (-5.46%) • MKT CAP: $181.3M
gross-margins
48.50%
LAST: $68.08 (+1.91%) • MKT CAP: $212.7M
gross-margins
57.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (STIM VS. UTMD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | STIM | UTMD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 48.50% | 57.10% | -8.60 | UTMD | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 26.90% | -61.90 | UTMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 10.8x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -11.25% | 6.73% | -17.98 | UTMD | /fcf-yield <GO> |
| Operating Margin | -21.10% | 29.60% | -50.70 | UTMD | /operating-margins <GO> |
| Net Profit Margin | -26.10% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 99.20% | -5.80% | +105.00 | STIM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.87% | -1.87 | UTMD | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 4/9 | +1.00 | STIM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.9 | 27.2 | +28.70 | STIM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $181.3M | $212.7M | -$31.3M | UTMD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | STIM REV | UTMD REV | STIM GROSS % | UTMD GROSS % | STIM FCF | UTMD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $149.2M | $38.5M | 48.5% | 57.1% | -$20.4M | $14.3M |
| FY 2024 | $74.9M | $40.9M | 72.3% | 59.0% | -$31.0M | $14.6M |
| FY 2023 | $71.3M | $50.2M | — | — | -$32.0M | $22.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
STIM // BETA —
UTMD // BETA —